Cancer; ophthalmic disease

INDICATION: Pancreatic cancer; age-related macular degeneration (AMD)

Cell culture and mouse studies suggest a SEMA3A-based fusion protein could help treat metastatic pancreatic cancer and AMD. The fusion protein

Read the full 275 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE